New York Cancer Specialists is delivering state-of-the-art medical technology and world-class cancer care to all of our New York communities
New York, NY #2 in Cancer Overview Rankings Book Appointment Cancer Scorecard Cancer ratings are based on analysis of factors such as patient outcomes in the medical and surgical treatment of cancer, volume of high-risk patients, patient experience, nurse staffing, and advanced clinical technologies...
New York Cancer Specialists is delivering state-of-the-art medical technology and world-class cancer care to all of our New York communities
A review of 45 National Cancer Institute (NCI)-designated websites from January to May of 2016 showed that leading U.S. cancer centers increasingly present integrative medicine content on their websites, and a majority of them provide these services to patients in the same health systems, accord...
Principal Findings We determine that inpatient costs were 27% higher (95% CI 0.252, 0.285), but length of stay was 12% shorter (95% CI 0.131, 0.100), in Comprehensive Cancer Centers relative to community hospitals. Conclusions The results imply that, in New York State, Comprehensive Cancer ...
The National Comprehensive Cancer Network released a study that found 93 percent of cancer centers in the U.S. are experiencing the shortage. "Sometimes it may be a delay in therapy until an agent becomes available," said Dr. Robert W. Carlson, CEO of the National Comprehensive Cancer Network...
Our experts at NYU Langone’s Perlmutter Cancer Center work together to carry out groundbreakingbasic and translational research. We have one of the largest portfolios ofclinical trials for pancreatic cancerin the country and are one of the few centers in the United States with multiple clinical tr...
Imaging Network], Alliance for Clinical Trials in Oncology, NRG Oncology [formerly the National Surgical Adjuvant Breast and Bowel Project, Radiation Therapy Oncology Group, and Gynecologic Oncology Group], or other) with SWOG centers and/or investigators contributing to patient accrual were included. ...
MSK has long been a leader in early detection, precise diagnosis, and individually tailored treatments for cancer. We continue to drive innovations as one of 52 National Cancer Institute–designated Comprehensive Cancer Centers, with state-of-the-art science flourishing side by side with clinical stu...